The Latest Breaking News from biotechnology

There is a need for a holistic approach to tackle the problem of severe acute malnutrition reveals a research study carried out by St. John’s Research Institute (SJRI) through funding received from Karnataka Biotechnology and Information Technology Services (KBITS).

The Chart of the Day belongs to the biotechnology company Argenx (ARGX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature...

India can become a leading player in the field of biomanufacturing and help the Quad, of India, Japan, Australia and the United States, to compete in this key area

The biotech industry is well-positioned to grow, thanks to breakthrough advances, rising chronic illness and government support. So, fundamentally solid biotech stocks, Genmab (GMAB) and Exelixis (EXEL) may be worth buying now. Read on.

The biotechnology industry has been stoked by a blaze of advancements, breakthroughs, and investments, setting the stage for remarkable growth. With the industry catching a favorable wind, it could be wise to invest in robust biotech stocks MannKind Corporation (MNKD), POINT Biopharma (PNT), and LAVA Therapeutics (LVTX), which are primed…

The biotech industry is well-positioned to witness significant growth with government support and breakthrough developments. Therefore, biotech stocks BioNTech SE (BNTX), Acorda Therapeutics (ACOR), and Shionogi (SGIOY) might be solid buys. Read on.

The biotech industry is well-positioned to witness significant growth due to technological advancements and government spending. Moreover, given the sector’s defensive nature, biotech stocks Amicus Therapeutics (FOLD), Corcept Therapeutics (CORT), and Harmony Biosciences (HRMY) might be solid buys in 2023. Read on.

Coupled with fears about an economic downturn, several other headwinds could keep the biotechnology industry under significant pressure. Given this backdrop, fundamentally weak biotech stocks Day One Biopharmaceuticals (DAWN), Northwest Biotherapeutics (NWBO), and Ocugen (OCGN), with bearish momentum, could be avoided in April. Read on….

Saudi Arabia and South Korea are working to develop a comprehensive strategic cooperation, especially in the field of petrochemicals, energy supply chains, and the exchange of expertise and technological industries, with Seoul expressing interest in more vital partnerships that would also cover biotechnology industries and startups. Lee Young, South Korean…

The Chart of the Day belongs to the biotechnology company Aldeyra Therapeutics (ALDX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart...

The biotech industry is predicted to grow steadily, driven by significant advancements, advancements in agriculture, biotechnology, and government initiatives. Also, during market downturns, the biotech sector tends to be more defensive than others. So, LAVA Therapeutics (LVTX) could be an ideal buy now. However, considering the lingering macroeconomic headwinds, fundamentally…